Avalon GloboCare Corp. 8-K

What Happened

• Avalon GloboCare Corp. (ALBT) filed a Current Report on Form 8-K on January 20, 2026, disclosing that it issued a press release announcing updates related to its KetoAir™ breathalyzer device.
• The press release is included as Exhibit 99.1 to the 8-K. The company filed the disclosure under Item 7.01 (Regulation FD Disclosure).

Key Details

• Filing date: January 20, 2026.
• Subject: updates concerning the KetoAir™ breathalyzer device (details provided in press release, Exhibit 99.1).
• Regulatory note: the disclosure is made under Regulation FD and the company states the information is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act and is not automatically incorporated by reference into other filings.

Why It Matters

• Product updates for KetoAir™ are a company-released development that could be relevant to investors tracking Avalon GloboCare’s product pipeline and commercialization progress.
• Because the information was shared as a Regulation FD disclosure via press release, it was made public to ensure broad investor access; however, the company limited certain legal filing implications (not deemed “filed” under Section 18).